CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).

Saved in:

Bibliographic Details
Title:	CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).
Authors:	Magnus, Björkholm¹ magnus.bjorkholm@karolinska.se, Tomas, Andersson^2,3, Anders, Ahlbom^2,3, Eva, Ösby¹
Source:	European Journal of Haematology. Jun2008, Vol. 80 Issue 6, p477-482. 6p. 1 Chart, 2 Graphs.
Database:	Academic Search Ultimate

Description
ISSN:	09024441
DOI:	10.1111/j.1600-0609.2008.01062.x